Literature DB >> 8526449

[Results of a controlled trial comparing 3 suture threads at slow resorption for the closure of supra-umbilical midline laparotomies].

L Bresler1, P J Courbey, L Feldman, J Bilweiss, J M Tortuyaux, P Rauch, P Boissel, J Grosdidier.   

Abstract

A randomized prospective trial was carried out between September 1987 and February 1989 to compare 3 different absorbable sutures (polyglactine 910, polydioxanone I, polydioxanone II) for closure of the abdominal wall after upper midline laparotomy for elective operations. The technique used to close the fascia was always a continuous suture. The criteria used to assess the results were the development of wound infection and wound dehiscence in the early postoperative period, and the development of suture sinuses and incisional hernia 1 year after operation. The early postoperative results in 235 patients revealed no wound infection and no -wound dehiscence. Suture sinuses developed in 4 patients (2%) 2 months after operation, but resolved spontaneously. We reviewed 203 patients after one year. The total number of incisional hernias detected 1 year postoperatively was 22 cases (11%), (polyglactine 910, 14.2%; polydioxanone I, 11.2%; polydioxanone II, 8.4%). The difference between the 3 groups was not statistically significant. The results of the trial indicate that absorbable sutures have a very low incidence of suture sinuses, and that polydioxanone II seems to be a good choice for closing laparotomies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526449

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  2 in total

Review 1.  Meta-analysis on Materials and Techniques for Laparotomy Closure: The MATCH Review.

Authors:  N A Henriksen; E B Deerenberg; L Venclauskas; R H Fortelny; M Miserez; F E Muysoms
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

2.  Hernia reduction following laparotomy using small stitch abdominal wall closure with and without mesh augmentation (the HULC trial): study protocol for a randomized controlled trial.

Authors:  Patrick Heger; Manuel Feißt; Johannes Krisam; Christina Klose; Colette Dörr-Harim; Solveig Tenckhoff; Markus W Büchler; Markus K Diener; André L Mihaljevic
Journal:  Trials       Date:  2019-12-16       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.